The drug Tamiflu is known to be the most effective medication for bird flu cases

The Food & Drug Administration in America has announced that stronger warnings are required for the influenza medication Tamiflu. The warnings on the labeling of the medication must now mention the unusual and rare instances of abnormal behaviour and delirium that have been reported in a few cases. In some of these cases the abnormal behaviour read to patients injuring themselves and then a few cases even death.

The labeling of the flu drug Tamiflu will continue to point out that people using the medication should be monitored for any signs of unusual actions or behaviour and you should call your doctor immediately if you observe anything. Despite the warnings regarding the use of the Tamiflu medication both the Food & Drug Administration and Roche who manufacture the drug say that they cannot conclusively prove that it is the Tamiflu that has caused these abnormal instances of behaviour and that it could be due to the fact that the influenza virus has on its own caused cause psychiatric events.

Most of the cases of psychiatric problems in influenza patients have occurred in Japan where the use of Tamiflu is extremely widespread. In fact Japan is the largest market in the world for Tamiflu. Roche has been fully cooperative in getting the new warnings printed on the labelling and has been working with the Food & Drug Administration on the changes. Roche has sent out letters to doctors all over America to inform them about these changes.

The drug Tamiflu is known to be the most effective medication to counteract the effects of the H5N1 bird flu virus and the World Health Organisation has recommended that nations stock up with the medication as a precaution should a contagious bird flu virus break out.  The Tamiflu drug is mainly used for dealing with regular flu viruses which occur all over the world and is not just a bird flu drug.